Recurrent Transient Global Amnesia


About this study

This study seeks to examine the characteristics of recurrent transient global amnesia, a clinical syndrome characterized by recurrent episodes of anterograde amnesia lasting up to 24 hours. Identification of factors contributing to recurrence will help to identify underlying mechanisms of these events and guide management.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:     

  • Diagnosis of one or more episodes of Transient Global Amnesia

Exclusion Criteria:     

  • Diagnosis of another medical condition that could explain the patient’s symptoms

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nathan Young, D.O.

Closed for enrollment

Contact information:

Nathan Young D.O.


More information


Publications are currently not available

Mayo Clinic Footer